Pharmaceutical Research & Consulting Inc Report issue

For profit Phase 2
Founded: Dallas TX United States (1979)
Status: No NME R&D (1979)

Organization Overview

First Clinical Trial
2002
NCT00658255
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2002

Timeline

NOW
  • Now

Active Ingredients

Drugs in Phase 2 Trials (2)

budesonide (rhinocort) (1 trial)

formoterol (foradil) (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Asthma (Phase 2)

Overview

  • Highest Phase: Phase 2
  • # of Trials: 1
  • # of Trial APIs: 2